Kallum Titchmarsh Analyst PerformanceVice President, Healthcare Equity Analyst at Morgan StanleyKallum Titchmarsh is a stock analyst at Morgan Stanley focused in the medical sector, covering 13 publicly traded companies. Over the past year, Kallum Titchmarsh has issued 21 stock ratings, including buy and hold recommendations. While full access to Kallum Titchmarsh's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Kallum Titchmarsh's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings24 Last 1 YearsBuy Recommendations40.91% 9 Buy RatingsCompanies Covered13 Unique Companies Ratings Distribution22RatingsDistribution of strong buy, buy, hold, and sell ratings by Kallum Titchmarsh.RatingPercentageCount Strong Buy0.0%0 ratings Buy40.9%9 ratings Hold59.1%13 ratings Sell0.0%0 ratingsOut of 22 total stock ratings issued by Kallum Titchmarsh at Morgan Stanley, the majority (59.1%) have been Hold recommendations, followed by 40.9% Buy.Best & Worst CallsBest Call000.0%INSPFeb 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%INSPMay 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNYSE61.5% of companies on NYSE8 companiesNASDAQ38.5% of companies on NASDAQ5 companiesKallum Titchmarsh, an analyst at Morgan Stanley, currently covers 13 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.Coverage FocusSector IconSectorPercentageMedical12 companies92.3%Manufacturing1 company7.7%Kallum Titchmarsh of Morgan Stanley specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.Coverage IndustriesIndustryPercentageMED INSTRUMENTS3 companies23.1%MEDICAL SERVICES2 companies15.4%MED - BIOMED/GENE2 companies15.4%MEDICAL INFO SYS2 companies15.4%SURGICAL, MEDICAL, AND DENTAL INSTRUMENTS AND SUPPLIES1 company7.7%MED PRODUCTS1 company7.7%MED - GENERIC DRG1 company7.7%MED/DENTAL - SUPP1 company7.7% Kallum Titchmarsh's Ratings History at Morgan Stanley Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsMTDMettler-Toledo International5/12/2026Lower Price Target$1,082.57$1,275.00Equal Weight$0.0000.00% ROIDHRDanaher4/22/2026Lower Price Target$184.11$255.00Overweight$0.0000.00% ROIDHRDanaher4/22/2026Lower Price Target$181.20$255.00Overweight$0.0000.00% ROIMMEDMiniMed Group3/31/2026Initiated Coverage$14.35$19.00Overweight$0.0000.00% ROIAAgilent Technologies3/3/2026Lower Price Target$115.83$160.00Overweight$0.0000.00% ROIGRALGRAIL2/24/2026Lower Price Target$43.03$60.00Equal Weight$0.0000.00% ROIWATWaters2/22/2026Lower Price Target$333.41$350.00Equal Weight$0.0000.00% ROIINSPInspire Medical Systems2/18/2026Set Price Target$61.69$60.00$0.0000.00% ROIMTDMettler-Toledo International2/10/2026Lower Price Target$1,409.51$1,475.00Equal Weight$0.0000.00% ROIINSPInspire Medical Systems12/2/2025Reiterated Rating$126.88$130.00Equal Weight$0.0000.00% ROIMTDMettler-Toledo International12/2/2025Initiated Coverage$1,467.73$1,550.00Equal Weight$0.0000.00% ROIAAgilent Technologies12/2/2025Initiated Coverage$150.08Overweight$0.0000.00% ROIPSNLPersonalis12/1/2025Boost Price Target$9.68$11.00Equal Weight$0.0000.00% ROIADPTAdaptive Biotechnologies12/1/2025Initiated Coverage$18.79$21.00Equal Weight$0.0000.00% ROIWSTWest Pharmaceutical Services12/1/2025Initiated Coverage$274.13$285.00Equal Weight$0.0000.00% ROIWATWaters12/1/2025Initiated Coverage$397.89$423.00Equal Weight$0.0000.00% ROIDHRDanaher12/1/2025Initiated Coverage$224.21$270.00Overweight$0.0000.00% ROITXG10x Genomics12/1/2025Reiterated Rating$18.08$20.00Equal Weight$0.0000.00% ROICRLCharles River Laboratories International12/1/2025Set Price Target$176.42$185.00$0.0000.00% ROIPENPenumbra7/31/2025Boost Price Target$258.62$266.00Equal Weight$0.0000.00% ROIINSPInspire Medical Systems7/15/2025Lower Price Target$130.17$182.00Overweight$0.0000.00% ROIINSPInspire Medical Systems5/6/2025Lower Price Target$154.06$200.00Overweight$00.0000.00% ROIPENPenumbra2/19/2025Boost Price Target$270.99$260.00Equal Weight$000.0000.00% ROIINSPInspire Medical Systems2/11/2025Lower Price Target$180.96$220.00Overweight$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel NicolausRaymond James FinancialBMO Capital Markets Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
